Category: Washington Post

Drop in childhood vaccinations during pandemic may raise risk of outbreaks of other diseases when schools reopen, CDC says

Read the full post on Health

Two members of an FDA advisory committee quit after approval of controversial Alzheimer’s drug

The FDA decision to approve Aduhelm set off a firestorm because critics say there is scant evidence the drug is effective.

Biden’s global vaccine strategy draws scrutiny ahead of G-7 pandemic talks

As the president seeks to restore America’s luster abroad, he faces multiple diplomatic challenges at his first foreign meeting

Washington announces cannabis giveaway in state-approved ‘joint for jabs’ vaccine campaign

So-called “joints for jabs” and similar campaigns have been around for months, with cannabis activist groups and dispensaries offering joints for vaccines. Now, a state itself is promoting the idea.

Delta variant accounts for 6 percent of new U.S. coronavirus infections

But vaccines appear to be highly effective in blocking symptoms of the latest, fast-spreading version of the coronavirus, health officials reported June 8.

Mastercard Foundation donates $1.3 billion to boost Africa’s coronavirus response

The money is intended to be used to acquire vaccines for more than 50 million people, boost the continent’s vaccine manufacturing and strengthen public health institutions.

Coronavirus questions answered: Can a booster for covid-19 and a flu shot be taken at the same time?

There’s no a definitive timeline on when boosters will be necessary, so health authorities have not provided clear recommendations on how those shots should be administered.

The facts about multivitamins

Here is what you need to know about the research, label claims and other details about these supplements.

Scientists begin to unravel the mysteries of the coronavirus and brains

Even as the pandemic appears ready to recede in the United States, dropping below an average of 30,000 new cases daily, it will take years to more fully understand the way the virus afflicts the brain.

FDA approves first drug intended to slow cognitive decline caused by Alzheimer’s disease

It is the first drug cleared that is designed to alter the course of the disease by slowing the deterioration of brain function — not just to ease symptoms.